The Role of Gut Microbiota on Idiopathic Pulmonary Fibrosis Mediated by Circulating Inflammatory Proteins: A Two-Step, Two-Sample Mendelian Randomization Study
Hongyu Zhu, Caihua Chen, Haixie Guo, Bo Zhang, Quanteng Hu
{"title":"The Role of Gut Microbiota on Idiopathic Pulmonary Fibrosis Mediated by Circulating Inflammatory Proteins: A Two-Step, Two-Sample Mendelian Randomization Study","authors":"Hongyu Zhu, Caihua Chen, Haixie Guo, Bo Zhang, Quanteng Hu","doi":"10.1111/crj.70120","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Persistent inflammation is a crucial characteristic of idiopathic pulmonary fibrosis (IPF). Gut microbiota (GM) contribute to the occurrence and development of several pulmonary diseases through the “gut–lung axis.” The genetic role of GM in IPF and the mediating effect of circulating inflammatory proteins.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A single nucleotide polymorphism (SNP) was used as an instrumental variable (IV) for exposure to evaluate the causal relationship between exposure and outcome. A two-step, two-sample Mendelian randomization study mainly based on an “inverse variance weighted (IVW)” approach was performed to explore the causal relationship between GM and IPF mediated by circulating inflammatory proteins.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The IVW way illustrated 12 taxa (Bacillales, Gastranaerophilales, Selenomonadales, Family XIII, Bacteroidaceae, <i>Bacteroides</i>, and <i>Actinomyces</i>, <i>Bifidobacterium</i>, <i>Oscillibacter</i>, <i>Ruminococcus gnavus</i>, <i>Subdoligranulum</i>, <i>Veillonella</i>) of GM and 8 circulating inflammatory proteins (CCL11, CXCL6, CXCL9, CCL8, CCL7, NRTN, STAMPB, and TGFa) had suggestive evidence of causality on IPF. The mediation MR demonstrated the causal pathway from <i>Actinomyces</i> to IPF was partly mediated by CCL11 (the mediation effect: 0.063, 95% CI [1.016–1.126]; <i>p</i> = 0.004) with a mediation proportion of 13.035%.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>These findings may suggest a genetically predicted association between GM and IPF mediated by circulating inflammatory proteins.</p>\n </section>\n </div>","PeriodicalId":55247,"journal":{"name":"Clinical Respiratory Journal","volume":"19 9","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/crj.70120","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/crj.70120","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Persistent inflammation is a crucial characteristic of idiopathic pulmonary fibrosis (IPF). Gut microbiota (GM) contribute to the occurrence and development of several pulmonary diseases through the “gut–lung axis.” The genetic role of GM in IPF and the mediating effect of circulating inflammatory proteins.
Methods
A single nucleotide polymorphism (SNP) was used as an instrumental variable (IV) for exposure to evaluate the causal relationship between exposure and outcome. A two-step, two-sample Mendelian randomization study mainly based on an “inverse variance weighted (IVW)” approach was performed to explore the causal relationship between GM and IPF mediated by circulating inflammatory proteins.
Results
The IVW way illustrated 12 taxa (Bacillales, Gastranaerophilales, Selenomonadales, Family XIII, Bacteroidaceae, Bacteroides, and Actinomyces, Bifidobacterium, Oscillibacter, Ruminococcus gnavus, Subdoligranulum, Veillonella) of GM and 8 circulating inflammatory proteins (CCL11, CXCL6, CXCL9, CCL8, CCL7, NRTN, STAMPB, and TGFa) had suggestive evidence of causality on IPF. The mediation MR demonstrated the causal pathway from Actinomyces to IPF was partly mediated by CCL11 (the mediation effect: 0.063, 95% CI [1.016–1.126]; p = 0.004) with a mediation proportion of 13.035%.
Conclusions
These findings may suggest a genetically predicted association between GM and IPF mediated by circulating inflammatory proteins.
背景持续炎症是特发性肺纤维化(IPF)的一个重要特征。肠道微生物群(GM)通过“肠-肺轴”促进几种肺部疾病的发生和发展。转基因在IPF中的遗传作用及循环炎症蛋白的介导作用。方法采用单核苷酸多态性(SNP)作为暴露的工具变量(IV),评价暴露与预后的因果关系。一项主要基于“逆方差加权(IVW)”方法的两步、两样本孟德尔随机化研究,旨在探讨GM与循环炎症蛋白介导的IPF之间的因果关系。结果IVW方法显示12个类群(芽胞杆菌、嗜气胃杆菌、单胞硒门、13科、拟杆菌科、拟杆菌科、放线菌科、双歧杆菌、Oscillibacter、瘤胃球菌、小肠子菌、小肠子菌)的GM和8个循环炎性蛋白(CCL11、CXCL6、CXCL9、CCL8、CCL7、NRTN、STAMPB、TGFa)与IPF存在因果关系。中介MR表明CCL11部分介导了放线菌与IPF的因果通路(中介效应:0.063,95% CI [1.016-1.126]; p = 0.004),中介比例为13.035%。结论:这些发现可能表明GM和循环炎症蛋白介导的IPF之间存在遗传预测关联。
期刊介绍:
Overview
Effective with the 2016 volume, this journal will be published in an online-only format.
Aims and Scope
The Clinical Respiratory Journal (CRJ) provides a forum for clinical research in all areas of respiratory medicine from clinical lung disease to basic research relevant to the clinic.
We publish original research, review articles, case studies, editorials and book reviews in all areas of clinical lung disease including:
Asthma
Allergy
COPD
Non-invasive ventilation
Sleep related breathing disorders
Interstitial lung diseases
Lung cancer
Clinical genetics
Rhinitis
Airway and lung infection
Epidemiology
Pediatrics
CRJ provides a fast-track service for selected Phase II and Phase III trial studies.
Keywords
Clinical Respiratory Journal, respiratory, pulmonary, medicine, clinical, lung disease,
Abstracting and Indexing Information
Academic Search (EBSCO Publishing)
Academic Search Alumni Edition (EBSCO Publishing)
Embase (Elsevier)
Health & Medical Collection (ProQuest)
Health Research Premium Collection (ProQuest)
HEED: Health Economic Evaluations Database (Wiley-Blackwell)
Hospital Premium Collection (ProQuest)
Journal Citation Reports/Science Edition (Clarivate Analytics)
MEDLINE/PubMed (NLM)
ProQuest Central (ProQuest)
Science Citation Index Expanded (Clarivate Analytics)
SCOPUS (Elsevier)